JP Morgan Chase
NBP

JP Morgan Chase’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

JP Morgan Chase’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Sell
57,489
-74,341
-56% -$249K ﹤0.01% 5699
2025
Q4 		$525K Sell
131,830
-18,334
-12% -$81.1K ﹤0.01% 4988
2025
Q3 		$568K Buy
+150,164
New +$510K ﹤0.01% 4942
2025
Q2 		– Sell
-5,000
Closed -$4.12K – 7360
2025
Q1 		$4.12K Buy
+5,000
New +$4.75K ﹤0.01% 6454
2023
Q4 		– Sell
-477,895
Closed -$631K – 7681
2023
Q3 		$631K Sell
477,895
-119,479
-20% -$262K ﹤0.01% 4349
2023
Q2 		$1.79M Buy
597,374
+37,079
+7% +$119K ﹤0.01% 3618
2023
Q1 		$1.94M Sell
560,295
-217,250
-28% -$1.05M ﹤0.01% 3565
2022
Q4 		$3.25M Buy
777,545
+771,682
+13,162% +$2.92M ﹤0.01% 3180
2022
Q3 		$24K Sell
5,863
-243,109
-98% -$1.84M ﹤0.01% 5756
2022
Q2 		$2.81M Buy
248,972
+132,835
+114% +$1.59M ﹤0.01% 3277
2022
Q1 		$1.89M Buy
116,137
+113,787
+4,842% +$2.92M ﹤0.01% 3805
2021
Q4 		$111K Sell
2,350
-23,940
-91% -$1.44M ﹤0.01% 5629
2021
Q3 		$1.91M Sell
26,290
-124,008
-83% -$8.97M ﹤0.01% 3836
2021
Q2 		$12.6M Buy
150,298
+7,075
+5% +$467K ﹤0.01% 2231
2021
Q1 		$6.94M Buy
143,223
+143,211
+1,193,425% +$7.77M ﹤0.01% 2696
2020
Q4 		$1K Sell
12
-6,049
-100% -$238K ﹤0.01% 5550
2020
Q3 		$233K Buy
6,061
+5,914
+4,023% +$195K ﹤0.01% 4288
2020
Q2 		$4K Buy
+147
New +$3.04K ﹤0.01% 5202

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase's NBP Position: Q1 2026 in Review

JP Morgan Chase reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 56% in Q1 2026, selling an estimated $249K and leaving 57,489 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #5699.

JP Morgan Chase first reported a position in NBP in Q2 2020 and has held it in 18 quarters since. The position peaked at $12.6M in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • JP Morgan Chase held 57,489 shares of NovaBridge Biosciences American Depositary Shares worth $129K as of Q1 2026.
  • JP Morgan Chase sold 74,341 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $249K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5699 holding.
  • JP Morgan Chase first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 18 quarters since.
  • JP Morgan Chase's NovaBridge Biosciences American Depositary Shares position peaked at $12.6M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.